Department of Biophysics, The University of Texas Southwestern Medical Center, Dallas, Texas, USA.
Br J Pharmacol. 2022 Jul;179(14):3487-3495. doi: 10.1111/bph.15627. Epub 2021 Aug 12.
The cannabinoid CB receptor is the most abundant G protein coupled receptor (GPCR) in the central nervous system, which mediates the functional response to endocannabinoids and Cannabis compounds. A variety of ligands for CB receptors have been developed as promising drug candidates for the treatment of neurological disorders. New high-resolution structures of CB receptor in different functional states have significantly improved our molecular understanding of CB ligand interactions, selectivity, receptor activation and allosteric modulation. These advances have paved the way for development of novel ligands for different therapeutic applications. In this review, we describe the structural determinants for modulation of CB receptors by different types of ligands, as well as the differences between CB and its homologous, the CB receptor. LINKED ARTICLES: This article is part of a themed issue on Structure Guided Pharmacology of Membrane Proteins (BJP 75th Anniversary). To view the other articles in this section visit http://onlinelibrary.wiley.com/doi/10.1111/bph.v179.14/issuetoc.
大麻素 CB 受体是中枢神经系统中含量最丰富的 G 蛋白偶联受体(GPCR),介导内源性大麻素和大麻素化合物的功能反应。已经开发出各种 CB 受体配体,作为治疗神经紊乱的有前途的药物候选物。不同功能状态下 CB 受体的新高分辨率结构显著提高了我们对 CB 配体相互作用、选择性、受体激活和变构调节的分子理解。这些进展为不同治疗应用的新型配体的开发铺平了道路。在这篇综述中,我们描述了不同类型配体调节 CB 受体的结构决定因素,以及 CB 受体与其同源物 CB 受体之间的差异。相关文章:本文是膜蛋白结构导向药理学专题的一部分(BJP 75 周年纪念)。要查看本节中的其他文章,请访问 http://onlinelibrary.wiley.com/doi/10.1111/bph.v179.14/issuetoc/。